This is a preview of subscription content, log in via an institution to check access.
References
Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997; 278: 51–7.
Raffin D, Zaragoza J, Georgescou G, et al. High-frequency ultrasound imaging for cutaneous neurofibroma in patients with neurofibromatosis type I. Eur J Dermatol 2017; 27: 260–5.
Brems H, Chmara M, Sahbatou M, et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007; 39: 1120–6.
Idogawa M, Hida T, Tanaka T, et al. Renal angiomyolipoma (AML) harboring a missense mutation of TSC2 with copy-neutral loss of heterozygosity (CN-LOH). Cancer Biol Ther 2020; 21: 315–9.
Upadhyaya M, Huson SM, Davies M, et al. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970–2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 2007; 80: 140–51.
Pinna V, Lanari V, Daniele P, et al. p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet 2015; 23: 1068–71.
Trevisson E, Morbidoni V, Forzan M, et al. The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas. Mol Genet Genomic Med 2019; 7: e616.
Tsipi M, Poulou M, Fylaktou I, et al. Phenotypic expression of a spectrum of neurofibromatosis type 1 (NF1) mutations identified through NGS and MLPA. J Neurol Sci 2018; 395: 95–105.
Mattocks C, Baralle D, Tarpey P, Ffrench-Constant C, Bobrow M, Whittaker J. Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11–17 distinct from the GAP related domain. J Med Genet 2004; 41: e48.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure
Acknowledgement: the analyses were supported by the Initiative on Rare and Undiagnosed Diseases funded by the Japan Agency for Medical Research and Development. Financial support: none. Conflicts of interest: none.
About this article
Cite this article
Hida, T., Idogawa, M., Ishikawa, A. et al. Neurofibromatosis type 1 without cutaneous neurofibromas: a rare genotype-phenotype correlation?. Eur J Dermatol 30, 608–609 (2020). https://doi.org/10.1684/ejd.2020.3861
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2020.3861